First test of new drug in healthy women seeks safety data
NCT ID NCT06908707
Summary
This early-stage study aimed to check the safety of a new drug called LAE102 in healthy postmenopausal women. Researchers gave single, increasing doses to 32 participants and closely monitored for any side effects. The main goal was to see how the body handles the drug and determine if it is safe enough for further testing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTMENOPAUSAL are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fortrea Clinical Trials
Daytona Beach, Florida, 32117, United States
Conditions
Explore the condition pages connected to this study.